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1. Introduction 
Type 2 diabetes is a progressive chronic disease that causes serious complications and 
decreases the life expectancy. According to 1997-98 population-based survey (TURDEP-I), 
the prevalence of diabetes was 7.2% in adult population of Turkey [1]. The second survey 
which was recently completed (TURDEP-II), indicated that the prevalence of diabetes 
increased by 90% within last 12 years and reached to 13.7% (undiagnosed 7.5%), which 
means that almost 6.5 million adults have diabetes in Turkey [2].  
Intensive control of glycemia and cardiovascular risk factors can significantly reduce the 
rate of acute and chronic complications, and increase the life expectancy and quality of life 
in patients with diabetes [3–6]. Early diagnosis, correct and intensive antidiabetes treatment, 
and effective follow-up were recommended to decrease the risk of complications [7]. 
Despite extensive evidence of benefits of tight glycemic control, large proportions of people 
with diabetes do not achieve target glycemic control.  
The use of clinical guidelines is the best strategy for the effective control of diabetes. There 
are multiple diabetes practice guidelines based on published data or derived from expert 
consensus and provide specific recommendations to diagnose diabetes and to achieve and 
maintain glycemic control. Previous studies reported non-adherence to evidence-based 
guidelines, which was based on physician factors, patient factors, and organizational factors 
[8–11].  
The national guidelines have particular importance to address local requirements. 
Therefore, Diabetes Study Group of The Society of Endocrinology and Metabolism of 
Turkey (SEMT) developed ‘Clinical Practice Guidelines for Diagnosis, Treatment, and 
Follow-up of Diabetes and Its Complications’ in 2006, which are reviewed and updated 
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biannually [12–14]. In comparison with ‘American Diabetes Association (ADA) Clinical 
Practice Recommendations’, the SEMT guidelines include more detailed information on 
diagnosis and follow-up of diabetes and its complications in addition to general information 
on diabetes. Furthermore, diabetes management on special and co-morbid conditions such 
as pregnancy, surgery, travel, vaccination, hypertension, hyperlipidemia, coronary artery 
disease was explained in detail in the SEMT guidelines. While target glycated hemoglobin 
A1c (A1C) is ≤6.5% in the SEMT guidelines, it is <7% in ADA guidelines [15]. The treatment 
algorithm in the SEMT guidelines has also some differences than that of ADA/European 
Association for the Study of Diabetes (EASD) guidelines [16]: initially lifestyle modification 
+ MET treatment; if A1C target is not reached in 2-3 months, other oral antidiabetics for A1C 
<8.5% or insulin treatment for A1C >8.5%; if initial A1C >10%, insulin or combination 
regimens are suggested from the beginning. If target A1C is not still obtained, basal-bolus 
insulin is started and MET treatment is retained if possible. 
The perception and use of SEMT guidelines by physicians in Turkey, however, are 
unknown.  
Therefore, we aimed to determine the physicians’ adherence to the SEMT diabetes 
guidelines in a study entitled “Adherence of physicians to guidelines for the management of 
type 2 diabetes: The ADMIRE study”. The main objectives of the ADMIRE study were to 
evaluate physicians’ adherence to SEMT diabetes guidelines, to determine the factors 
affecting physicians’ adherence, to evaluate the impact of physicians’ adherence to 
guidelines on glycemic control in diabetes mellitus, and to prospectively evaluate the impact 
of education of physicians on the adherence to guidelines. 
2. Patients and methods 
2.1. Study design 
2.1.1. Retrospective phase 
This was a patient-based, multi-centre, and non-interventional study. The study was 
composed of two phases: a retrospective phase and a prospective phase.  
For the retrospective phase, 200 Internal Medicine or Family Medicine physicians who 
involved in medical care of patients with type 2 diabetes were randomly selected to 
represent all geographical regions and hospital types. Of these physicians, 180 agreed to 
participate in the ADMIRE Study Group. The medical records of 1,790 patients with type 2 
diabetes (mean age, 58.710.9 years; female, 61.7%; duration of diabetes, 7.77.5 years, mean 
body mass index [BMI], 30.15.6 kg/m2; chronic complications, 58.6%) followed by 180 
physicians during last 12 months were reviewed to determine whether the patients were 
followed and treated according to SEMT guidelines. The number of visits was at least 4 for 
1,149 (64.2%) patients. 
The effects of following patient- and physician-related factors on adherence to guidelines 
were analyzed using data from retrospective phase: patients’ age, gender, diabetes duration, 
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BMI, presence and number of chronic complications, physicians’ specialty, and type of 
institution were considered as variables affecting guideline adherence.  
2.1.2. Prospective phase 
In this phase, physicians were educated on the basis of data obtained from retrospective 
phase. Before the education, 883 type 2 diabetes patients (female, 61.7%; mean age, 55.3±10.4 
years, duration of diabetes, 7.1±6.9 years, BMI, 30.4±5.4 kg/m2) who were under control by 
study physicians were included in the study during two months of recruitment period. 
These patients were followed up for four months including initial and control visits. 
Afterwards, recruitment of patients was stopped and physicians received education. The 
educations included one-day comprehensive training course with case presentations and 
distribution of a DVD and booklets on several complications of diabetes mellitus. Along 
with a hard copy of SEMT diabetes guidelines, and online access to education materials for 
three months. After the education of physicians, 1,613 type 2 diabetes patients (female 
58.7%, mean age, 56.7±10.8 years, duration of diabetes, 7.3±6.3 years, BMI, 30.3±5.3 kg/m2) 
who were under control by study physicians were included in the study during two months 
and then were followed up for four months with a control visit. Total duration of 
prospective phase was 15 months. 
The change in adherence of physicians to SEMT guidelines and glycemic control with 
education of physicians was evaluated. Furthermore, the effect of education on the rate of 
patients with regard to physicians’ adherence to guidelines for treatment of diabetes was 
determined.  
2.2. Parameters for adherence to guidelines 
Adherence to SEMT guidelines was assessed in three domains of medical history, physical 
examination, and laboratory evaluations; each domain was scored on a 10-point scale (0 for 
non-adherence, 10 for full adherence). The score for adherence to guidelines for overall 
diagnosis and follow-up procedures was calculated by multiplying the arithmetic mean of 
the adherence scores for medical history, physical examination, and laboratory evaluation 
by 10, and changed between 0 and 100. 
2.3. Glycemic control parameters 
The relation between the degree of adherence to SEMT guidelines and glycemic control of 
patients was evaluated. The glycemic control parameters were A1C ≤6.5% (≤48 mmol/mol), 
fasting blood glucose (FBG) levels 70–120 mg/dL, and 2-hour postprandial blood glucose 
(PPBG) levels <140 mg/dL. 
2.4. Statistical analyses 
Study data was summarized with descriptive statistics (number, percentages, mean, 
standard deviation). Spearman’s simple correlation coefficient (r) was calculated for the 
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correlation of between degree of adherence to guidelines and the levels of A1C, FBG, and 
PPBG. Student t test and analysis of variance (ANOVA) followed by post-hoc Tukey test 
were used to compare continuous data of two and three groups, respectively. Chi-square 
test or Mantel-Haenszel chi-square test was used for comparison of discrete data between 
groups. Statistical level of significance was defined as p<0.05. 
3. Results 
3.1. Physicians’ adherence to guidelines on retrospective phase 
Evaluation of physicians’ adherence to SEMT guidelines regarding medical history, physical 
examination, and laboratory evaluation showed that diagnosis and follow-up procedures 
were >75% compliant with SEMT guidelines for 869 patients (48.5%) (Table 1). Full 
physicians’ adherence to medical history, physical examination, and laboratory aspects of 
SEMT guidelines were met in 68.6%, 8.3%, and 19.2% of the patients, respectively. The mean 
adherence scores for medical history, physical examination, and laboratory aspects of SEMT 
guidelines were 8.83±2.21, 5.86±2.98, and 6.29±2.68, respectively. 
Physicians were adherent to guidelines in 565 patients (54.2%) for antidiabetic treatment. 
They applied insufficient treatment for 468 patients (44.9%) and unnecessarily aggressive 
treatment for 10 patients (1.0%). Management was adherent to guidelines in 859 patients 
(79.2%) for antihypertensive treatment, and in 578 patients (76.0%) for antilipid treatment 
approaches (Figure 1). 
3.2. Factors affecting physicians’ adherence on retrospective phase  
Patients’ age, gender, diabetes duration, BMI, presence and number of chronic 
complications were patient-related factors; type of institution and specialty were physician-
related factors whose effects on scores for adherence to guidelines were studied. For older 
patients and males, physicians’ adherence to guidelines was higher for laboratory 
evaluations. All aspects of guideline adherence were poor in patients with short duration (<5 
years) of diabetes and in the absence of chronic complications. Furthermore, physicians in 
state institutions and family practitioners had lower adherence scores for physical 
examination and laboratory evaluation (Table 2). 
3.3. Impact of adherence to guidelines on glycemic control on retrospective 
phase  
Degree of overall adherence for diagnosis and follow-up procedures to guidelines did not 
correlate with glycemic control parameters except a negative correlation with FBG levels in 
visit 2. However, there was a weak inverse correlation between physical examination 
adherence score and A1C (r=-0.058, p=0.045), FBG (r=-0.049, p=0.050), and PPBG (r=-0.073, 
p=0.030) levels in visit 1. There was also negative correlation between adherence to 
guidelines for laboratory evaluation and FBG in visit 1 (r=-0.051, p=0.039) and visit 2 (r=-
0.093, p=0.001) and between adherence to guidelines for medical history and FBG in visit 2 
(r=-0.073, p=0.008) and A1C in visit 3 (r=-0.097, p=0.007) (Table 3). 
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n % 
Medical historya
0 39 2.2 
2 30 1.7 
4 65 3.6 
6 111 6.2 
8 317 17.7 
10 1,228 68.6 
Mean score 8.83±2.21
Physical examinationsb
0 134 7.5 
1 80 4.5 
2 89 5.0 
3 112 6.3 
4 135 7.5 
5 177 9.9 
6 189 10.6 
7 220 12.3 
8 232 13.0 
9 273 15.3 
10 149 8.3 
Mean score 5.86±2.98
Laboratory evaluationc
0 146 8.2 
3.3 254 14.2 
6.7 1,046 58.4 
10 344 19.2 
Mean score 6.29±2.68
Overall diagnosis and follow-up proceduresd
<50 283 15.8 
50-75 638 35.6 
>75 869 48.5 
Mean score 69.94±20.27
a Adherence to guidelines was evaluated on a 10-point scale with 2-point for each of five items (diabetes symptoms, 
acute complications, chronic complications, cardiovascular risk factors, family history) that should be questioned for 
medical history. 
b Adherence to guidelines was evaluated on a 10-point scale with 1 or 0 point respectively for performing or not 
performing each of the following 10 physical examination items: height, weight, waist circumference, blood pressure 
and heart rate measurements; thyroid, abdominal, neurological, foot and fundus examination. 
c Adherence to guidelines was evaluated on a 10-point scale with 3.33 points for each of three laboratory tests (lipid 
profile, creatinine, and urinalysis). 
d Adherence to guidelines for overall diagnosis and follow-up procedures was evaluated on a 100-point scale, it was 
obtained by multiplying the mean of adherence scores for medical history, physical examination, and laboratory 
evaluation  by 10.  
Table 1. Physicians’ adherence to SEMT guidelines regarding medical history, physical examination, and 
laboratory evaluation. Data are given as number of patients and % or mean±standard deviation of score. 
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Figure 1. Physicians were adherent to guidelines for treatment. 
 
 Scores for adherence to SEMT guidelines 
Medical 
history 
Physical 
examinations
Laboratory 
evaluation 
Overall 
diagnosis and 
follow-up 
procedures 
Patient-related factors  
Age (years) <40 9.4±1.5 5.7±3.0 6.4±2.9 71.4±20.0 
40-49 8.8±2.2 5.6±3.0 6.2±2.8a 68.9±21.1 
50-59 8.8±2.2 5.8±3.1 6.6±2.8 70.8±21.6 
60-69 8.9±2.1 6.0±3.0 6.8±2.7 72.2±21.0 
≥70 8.7±2.4 6.0±2.8 6.9±2.6 72.1±20.3 
p 0.322 0.515 0.020 0.272 
Gender Male 8.9±2.2 5.9±3.0 6.8±2.7 72.1±20.8 
Female 8.8±2.2 5.8±3.0 6.5±2.8 70.6±21.0 
p 0.469 0.666 0.021 0.139 
Diabetes duration 
(years) 
0-5 8.7±2.3b 5.4±3.0c 6.3±2.9c 68.1±22.0c 
6-10 9.0±1.9 6.2±2.9 6.9± 2.6 74.0±19.3 
11-15 8.9±2.1 6.5±2.8 7.4±2.6 75.9±19.6 
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 Scores for adherence to SEMT guidelines 
Medical 
history 
Physical 
examinations
Laboratory 
evaluation 
Overall 
diagnosis and 
follow-up 
procedures 
Patient-related factors  
16-20 9.4±1.2 6.7±2.9 7.3±2.7 78.2±19.1 
>20 8.9±2.1 6.5±2.8 7.3±2.5 75.6±18.9 
p 0.003 <0.001 <0.001 <0.001 
Body mass index 
(kg/m2) 
<25 9.3±1.7 7.8±1.9 7.3±2.1 81.3±13.8 
25-26 9.5±1.5 8.0±1.8 7.5±2.2 83.6±13.4 
27-29 9.3±1.6 7.9±1.9 7.4±2.5 82.1±15.3 
30-39 9.5±1.3 8.0±1.7 7.3±2.4 82.7±13.6 
≥40 9.6±0.9 8.2±1.7 7.4±2.2 84.2±11.2 
p 0.278 0.635 0.922 0.619 
Chronic 
complications 
(number of 
systems involved)
None 9.4±1.4d 5.9±2.9e 6.6±2.7e 72.9±18.2e 
1 system 9.1±1.8 6.2±2.9 6.8±2.8 73.8±19.1e 
2 systems 9.4±1.2 6.4±2.8 6.9±2.7 75.8±17.2 
>2 systems 9.4±1.2 6.6±2.8 7.4±2.5 77.6±17.4 
p 0.020 0.007 0.001 0.003 
History of chronic 
complications 
Yes 9.3±1.5 6.3±2.8 7.0±2.7 75.4±18.2 
No 9.4±1.4 5.9±2.9 6.6±2.7 72.9±18.2 
p 0.096 0.002 0.002 0.008 
Physician-related factors
Type of 
institution 
State 8.7±1.9 5.5±2.6g 6.4±2.3g 68.7±18.7 
Private 9.1±1.5 6.4±2.4 6.7±2.3 73.9±17.7 
University 8.8±1.6 7.5±2.4 8.2±2.0 81.8±18.8 
p 0.550 0.008 0.041 0.035 
Specialty Family practice 9.0±1.4 5.1±2.5h 5.7±2.1h 65.9±16.1h 
Internal 
medicine
8.7±1.9 5.7±2.5 6.7±2.4 70.2±19.6h 
Endocrinology 9.6±1.8 7.9±1.7 7.9±1.4 84.5±8.7 
p 0.096 <0.001 0.003 0.002 
a p<0.05 versus 60-69 years and ≥70 years of age; b p<0.05 versus 16-20 years diabetes duration; c p<0.05 versus all other 
diabetes duration groups; d p<0.05 versus 1 system involvement; e p<0.05 versus >2 systems involvement; g p<0.05 
versus university; h p<0.05 versus endocrinology. 
Table 2. Effect of patient- and physician-related factors on scores for adherence to guidelines. Data are 
given as mean±standard deviation of score. 
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A1C: Glycated hemoglobin A1c; FBG: Fasting blood glucose, PPBG: 2-hour postprandial blood glucose.  
Table 3. Correlation coefficients (Spearman’s r) between degree of adherence to SEMT guidelines and the levels of A1C, FBG, and PPBG 
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The minimum levels of A1C, FBG, and PPBG were significantly associated with the degree 
of general adherence to guidelines (p<0.05, Table 4). The minimum levels of A1C, FBG, and 
PPBG were significantly lower in >75% adherence to SEMT guidelines. 
 
 
Adherence to SEMT guidelines 
p 
<50 50–75 >75 
A1C (%)     
Minimum 7.81.9 7.61.8 7.41.8 0.021 
Maximum 8.72.1 8.72.0 8.82.1 0.315 
FBG (mg/dL)     
Minimum 154.061.7 149.7162.2 139.851.2 <0.001 
Maximum 202.282.4 212.886.0 207.683.7 0.232 
PPBG (mg/dL)     
Minimum 201.389.1 195.969.6 180.969.9 0.001 
Maximum 248.993.8 246.787.9 250.690.6 0.809 
A1C: Glycated hemoglobin A1c; FBG: Fasting blood glucose, PPBG: 2-hour postprandial blood glucose.  
Data are given as mean±standard deviation.  
Table 4. The relation between the degree of adherence to SEMT guidelines for overall diagnosis and 
follow-up procedures and minimum and maximum levels of A1C, FBG, and PPBG during previous year 
3.4. Impact of education of physicians prospectively on the adherence to 
guidelines 
After the education of physicians, adherence scores to SEMT guidelines significantly 
increased for medical history, physical examination, and overall diagnosis and follow-up 
procedures (p<0.001), however, adherence score decreased significantly for laboratory 
evaluation (p<0.001) (Table 5). This might be caused due to the time limit between visits. 
Patients may not have yet their laboratory control or could not provide test results to their 
physicians. 
The percentage of patients whose physicians comply with guidelines for antidiabetic 
(p<0.001), antihypertensive (p<0.001) and antilipid (p=0.002) treatment were increased 
significantly with the education (Table 6). 
However, rate of patients under glycemic control was similar before and after the education 
of physicians. Furthermore the level of adherence to SEMT guidelines for overall diagnosis 
and follow-up procedures had no effect on glycemic control before or after the education, 
except that significantly more patients whose physician adhere to guidelines >75% had FBG 
<120 mg/dL in control visit before education (p<0.013) (Table 7).  
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Before education After education
p 
n % n %
Medical historya <0.001 
0 35 4.0 141 8.7  
2 109 12.3 51 3.2  
4 160 18.1 0 0.0  
6 106 12.0 0 0.0  
8 116 13.1 54 3.3  
10 359 40.6 1,370 84.8  
Mean score 6.79±3.24 8.81±3.08 <0.001 
Physical examinationsb <0.001 
0 14 1.6 122 7.5  
1 21 2.4 1 0.1  
2 20 2.3 7 0.4  
3 112 12.7 12 0.7  
4 417 47.1 50 3.1  
5 147 16.6 351 21.7  
6 36 4.1 194 12.0  
7 6 0.7 22 7.5  
8 23 2.6 41 2.5  
9 14 1.6 167 10.3  
10 75 8.5 549 34.0  
Mean score 4.65±2.12 7.02±2.95 <0.001 
Laboratory evaluationc <0.001 
0 58 6.6 235 14.5  
3.3 93 10.5 171 10.6  
6.7 473 53.4 859 53.2  
10 261 29.5 351 21.7  
Mean score 6.86±2.71 6.07±3.11 <0.001 
Overall diagnosis and follow-up proceduresd <0.001 
<50 225 25.4 203 12.6  
50-75 481 54.4 416 25.7  
>75 179 20.2 997 61.7  
Mean score 61.03±17.36 72.99±25.30 <0.001 
a Adherence to guidelines was evaluated on a 10-point scale with 2-point for each of five items (diabetes symptoms, 
acute complications, chronic complications, cardiovascular risk factors, family history) that should be questioned for 
medical history. 
b Adherence to guidelines was evaluated on a 10-point scale with 1 or 0 point respectively for performing or not 
performing each of the following 10 physical examination items: height, weight, waist circumference, blood presssure 
and heart rate measurements; tyroid, abdominal, neurological, foot and fundus examination. 
c Adherence to guidelines was evaluated on a 10-point scale with 3.33 points for each of three laboratory tests (lipid 
profile, creatinine, and urinalysis). 
d Adherence to guidelines for overall diagnosis and follow-up procedures was evaluated on a 100-point scale, it was 
obtained by multiplying the mean of adherence scores for medical history, physical examination, and laboratory 
evaluation by 10.  
Table 5. Physicians’ adherence to SEMT guidelines during prospective phase of the study before and 
after education of physicians on guidelines. Data are given as number of patients and % or 
mean±standard deviation of score. 
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Adherence to guidelines 
Before education After education 
p 
n % n % 
Antidiabetic treatment 
  Incompliant  283 40.0 440 32.5 <0.001 
    Insufficient treatment 253 35.7 301 22.2  
    Unnecessary treatment 30 4.2 139 10.3  
  Compliant 425 60.0 914 67.5  
Antihypertensive treatment 
  Incompliant  181 21.4 183 12.7 <0.001 
  Compliant 664 78.6 1,253 87.3  
Antilipid treatment 
  Incompliant  100 13.6 118 9.2 0.002 
  Compliant 634 86.4 1,170 90.8  
Table 6. Number and percentage of patients in terms of physicians’ adherence to SEMT guidelines for 
treatment of diabetes patients during prospective phase of the study before and after education of 
physicians on guidelines 
Beside this, A1C of the patients followed up after the education significantly decreased at 
control visit compared to baseline. Similarly the percentage of the patients at target A1C 
significantly increased at control visit compared to baseline, after the education. 
4. Discussion and conclusion 
The use of diabetes guidelines meeting national requirements is the most effective way to 
improve quality in practice; however, they must be effectively disseminated and 
implemented to obtain this goal. On the other hand, national studies mostly reported 
suboptimal level of physicians’ adherence to the guidelines [10, 11, 17, 18]. Similarly, we 
found that only for half of the diabetes patients, diagnosis and follow-up procedures were 
>75% compliant with current SEMT guidelines; and for 54.2% patients, antidiabetic 
treatment were adherent to guidelines. 
Lack of knowledge, reluctance to change practice, clinical inertia, time constraints, 
difficulties with referral systems, patient nonadherence for various reasons and deficiencies 
in healthcare system are some of the barriers affecting physicians’ adherence to guidelines 
[19–21]. Among these factors, clinical inertia is defined as "recognizing the problem but 
failure to act" by health care professionals in primary care [22–29]. The key issues in the 
 
S
ta
te
 o
f th
e
 A
rt o
f T
h
e
ra
p
e
u
tic E
n
d
o
crin
o
lo
g
y 
 
1
6
4
 
              
 
A1C: Glycated hemoglobin A1c; FBG: Fasting blood glucose, PPBG: 2-hour postprandial blood glucose.  
Table 7. The rate of patients under glycemic control before and after the education of physicians on guidelines on glycemic control with respect to
adherence to SEMT guidelines. Data are given as number of patients (%). 
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 Before After 
 Baseline Control Baseline Control 
A1C (%)  8.68 7.98 8.39 7.69 
FPG (mg/dL)  190.9 158.2 178.4 150.1 
PPG (mg/dL)  247.9 200.9 240.2 199.5 
Patients on target A1C 
(≤6.5%) (%)  
17.0 22.9 20.8 28.3 
Patients on target FBG 
(<120 mg/dL) (%) 
17.5 31.3 20.7 31.2 
Table 8. Glycemic control before and after the education. 
management of people with type 2 diabetes include early detection of problems, realistic 
goal setting, improved patient adherence, better knowledge and understanding of 
pharmaco-therapeutic treatment options and prompt intervention. Clinical inertia is due 
to at least three problems: overestimation of care provided; use of "soft" reasons to avoid 
intensification of therapy; and lack of education, training, and practice organization aimed 
at achieving therapeutic goals. Health care professionals must need to overcome clinical 
inertia and need to intensify therapy in an appropriate and timely manner. Using guidelines 
in the management of diabetes patients and continuous education of diabetes care providers 
are effective ways to overcome clinical inertia [24, 29]. In a 3-year trial on 345 internal 
medicine residents, feedback on performance given to medical resident primary care 
providers improved provider behaviour and lowered A1C levels [27]. We think that lower 
adherence of guidelines by the physicians who provide care for younger (<50 year old) 
patients, males, and patients with short duration (<5 years) of diabetes and patients without 
complications in the ADMIRE study might be linked to clinical inertia in this group of 
patients. 
Furthermore characteristics of patients and physicians can also influence clinical decision 
making and guideline adherence. McKinlay et al. showed that adherence to guidelines 
varied according to patients’ age and gender and physicians’ years of experience [30]. We 
also found that guideline adherence was influenced by patient-related factors such as 
gender, diabetes duration, and comorbid conditions. Unfortunately, new onset diabetes 
patients were less likely to receive best practice. Physician specialty and institution type 
were also contributing factors for guideline adherence; family practitioners and physicians 
in state institutions had lower adherence scores. 
Although overall adherence for diagnosis and follow-up procedures to guidelines did not 
affect the glycemic control, weak inverse correlations were noted between physical 
examination, laboratory evaluation and medical history adherence scores and the levels of 
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A1C, FBG, and PPBG in some visits. Even if the correlation coefficients were too low to 
speak about, glycemic control is better maintained with increasing adherence to guidelines. 
Yet, the minimum levels of A1C, FBG, and PPBG were significantly lower with the 
increasing degree of general adherence to guidelines. On the other hand, poorer adherence 
scores for laboratory evaluation in our study may be because of the short duration following 
the educational session. Due to non-interventional design of the study, we think that some 
of the patients could not be able to come to a control visit or might have missed their 
appointment.   
In a controlled study, Gerstein et al. [31] evaluated the effect of a national continuing 
medical education (CME) program designed to improve family physicians' implementation 
of diabetes-specific clinical practice guidelines. They found that compared to controls, 
participants who attended CME programs had improved their attitude, and knowledge. 
Moreover self-reported practice pattern of physicians regarding diabetes after one month 
but not after one year was also improved. Thus the education of physicians is effective to 
disseminate practice guidelines, but needs to be repeated periodically. We also 
hypothesized that specific training of physicians on SEMT guidelines would increase the 
adherence and improve patient outcomes. We provide to participating physicians one-day 
educational session along with a DVD and a hard copy of the guidelines. Adherence to 
SEMT guidelines significantly increased for overall diagnosis and follow-up procedures 
with the education. Compliance to guidelines for treatment of diabetes patients was also 
increased after education of physicians. However, glycemic control of patients was similar 
before and after the education, which may be due to relatively short duration (four 
months) of follow-up of patients.  
The major limitation of this study is that the effect of other factors on the adherence to 
guidelines such as patient nonadherence to appointments, failure to comply with requested 
laboratory evaluations or system-related factors could not be eliminated. However, this 
study has particular importance in terms of type 2 diabetes knowledge: it showed that local 
guidelines are crucial to improve the clinical care of patients and to increase life-expectancy 
and quality of life of patients. However, continuous education of physicians on these 
guidelines should be recognized as a necessity rather than an individual optional behaviour. 
For example setting regulations to physicians to receive CME periodically on a compulsory 
manner may be beneficial. 
4.1. Conclusions and recommendations 
The following conclusions and recommendations were inferred from the ADMIRE study: 
1. The physician adherence to diabetes guidelines is suboptimal in Turkey. 
2. Patients with old age, established disease and multiple chronic complications received 
better care which is in compliance with guidelines.  
3. Patients with short duration of diabetes, younger age, no complication, and males 
received less attention, this may be attributed to clinical inertia of care providers. 
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4. Specialists and physicians practicing in university settings followed guidelines better 
than family practitioners and physicians practicing in state institutions. 
5. Glycemic control is better maintained with increasing physicians’ adherence to 
guidelines. 
6. Education of physicians on SEMT guidelines significantly increased their adherence to 
guidelines. 
7. A better glycemic control is provided, unnecessary treatment is decreased and more 
rational treatment preferences are observed, after education. 
As a conclusion, the educational programs targeted towards family practitioners and state 
institutions, may improve guideline adherence and patients’ outcome. These programs 
should emphasize the preventive aspect of diabetes management rather than symptom-
based treatment approach, Better adherence to diabetes guidelines provide better glycemic 
control and, thus lower the number of chronic complications and slow the natural course 
(progression) of the disease.  
Appendix 
ADMIRE study group*:  
Taner Akdere, Cihansah Akdogan, Hatice Sule Akin, S. Ahmet Akin, Baris Akinci, Sertug 
Akkorlu, Ersin Akpinar, Derya Gunes Aksoy, Kamuran Aksoy, Osman Tevfik Aksoy, 
Ahmet Hamdi Aktan, Kursat Alam, Pervin Algan, Nuri Nazif Altiner, Derya Altintig, 
Abdullah Aricioglu, Cengiz Arslan, Erhan Atav, Serdar Ay, Teslime Ayaz, Akin Aydemir, 
Mehmet Aydemir, Neslihan Aydin, Mehmet Deniz Ayli, Serkan Bakirdogen, Mehmet 
Bastemir, Halil Basturkmen, Hur Baybuga, Zeynep Baykal, Taner Bayraktaroglu, Serdar 
Baysoy, Recep Bentli, Ali Ayberk Besen, Mehmet Besen, Dogan Nasir Binici, Serife Nur 
Boysan, Nafiz Bozdemir, Cemal Akin Bozoglu, Mustafa Budak, Selahattin Cakiroglu, 
Tolga Cakmak, Ayse Kargili Carlioglu, Taner Cavusoglu, Aslan Celebi, Murat Celik, 
Mustafa Cesur, Onur Cubukcu, Kursat Dal, Aysegul Gok Dalbeler, Askin Demirci, Hakan 
Demirci, Oguz Demirtas, Ibrahim Dinc, M.Aydin Dincer, Halil Dogan, Cemil Dolay, Erdal 
Duman, Halil Duran, Metin Durandurdu, Ercan Dursunoglu, Berna Dalmis Ekiz, Evren 
Eraytac, M. Emin Erdem, Fuat Erdemir, Seref Eren, Munire Erengul, Tayyibe Erkenez, 
Necip Ersan, Oznur Ertas, Cengiz Erten, Sebahattin Erten, Osman Eseler, Hurrem Ezergul, 
Mehmet Gemici, Hakan Gocturk, Erdem Gokdeniz, Sait Gonen, Ahmet Gozeten, Mehmet 
Gumus, Mehmet Gunay, Osman Sadi Gunaydin, Eren Gurkan, Idil Hallac, Aysin 
Harmanda, Taner Hasan, Ayhan Haspulat, Aysen Helvaci, Metin Ilhan, Nevzat Iliman, 
Ibrahim Ince, Ismet Onder Isik, Can Iyiiz, Aytac Kosova Iyikavak, Ibrahim Kahraman, 
Seyfi Kamberoglu, Gulgun Kandogan, Ayse Gul Karacam, Mahmut Celal Karakoc, Murat 
Karakurt, Nesibe Karakus, Abdullah Katki, Fatih Oner Kaya, Sebnem Gider Kaya, Sezgi 
Sevinc Kayikcioglu, Kamuran Kaynar, Yasemin Turkmen Kemal, Sakir Ozgur Keskek, 
Osman Keskin, Murat Kilic, Surur Kip, Guven Koc, Ozgur Kocabas, Serdal Korkmaz, 
Ahmet Kovac, Selim Kum, Hatice Kurdak, Ali Kutlucan, Baha Moral, Ilhan Murat, Ayhan 
 
State of the Art of Therapeutic Endocrinology 
 
168 
Mutlu, Selim Nalbant, Ayse Aysin Oge, Bulent Oguz, Ozer Oktayer, Iris Kavalali Oktem, 
Hasan Onat, Halil Ugur Oney, Mehmet Renan Ozakgun, M. Kemal Ozbek, Sevgi Ozcan, 
Ibrahim Ozdes, Adem Ozkara, Meryem Tek Ozokcu, Kemal Ozsahin, Mine Ozturk, 
Mustafa Ozturk, Pervin Pehlivan, Erol Pektas, Bekir Pocan, Hayri Polat, Halil Rakici, Esra 
Saatci, Huseyin Saglam, Ozlem Sahan, Hakan Sari, Ramazan Sari, Hakan Ziya Satir, Ilhan 
Satman, Mehmet Seker, Hakki Selcuk, H. Atilla Sengul, Ayhan Sonmez, Halil Sozmen, 
Yaser Suleymanoglu, Mustafa Gurkan Taskale, Alisan Taspinar, Nihat Tekden, Melek 
Tezcan, Mustafa Togan, Osman Nuri Topal, Fusun Topcugil, Tufan Tukek, Nezih Tuncay, 
Mehmet Turk, Idil Atac Turkmen, Sibel Ergun Turkmen, Pelin Tutuncuoglu, Asli Dogruk 
Unal, Tugrul Unat, Mehtap Erkmen Uyar, Ceyhun Varim, Mumin Varol, Feryal Atmaca 
Yalcin, Hamiyet Yilmaz Yasar, Hamza Yazici, Mehmet Yildiz, Zeki Yildiz, Zerrin 
Yildizbas, Mahmut Yilmaz, Mehmet Kaan Yilmaz, Hikmet Yuce, Yasar Yucel, Arif Yuksel, 
Iskender Yuksel, Adem Yurumez, Sefik Zeytunlu 
Author details 
Ilhan Satman 
Division of Endocrinology & Metabolism, Department of Internal Medicine,  
Istanbul Faculty of Medicine, Istanbul University,Istanbul, Turkey 
Sazi Imamoglu 
Division of Endocrinology & Metabolism, Department of Internal Medicine,  
Uludag University Faculty of Medicine, Bursa, Turkey 
Candeger Yilmaz 
Division of Endocrinology & Metabolism, Department of Internal Medicine,  
Ege University Faculty of Medicine, Izmir, Turkey 
ADMIRE Study Group 
ADMIRE Study Group members are listed in the Appendix 
Acknowledgement 
We thank to the members of the ADMIRE Study Group for their valuable contributions (see 
Appendix). Special thanks to Dr. Oktay Ozdemir and Murat Kirtis for their assistance with 
the preparation of the manuscript. We also thank to sanofi-Turkey for providing 
unrestricted and unconditioned grant for the study. 
This study was partly published/presented in the following journals/meetings: 
Original article: 
1. Satman İ, İmamoğlu Ş, Yılmaz C, ADMIRE Study Group. Adherence of physicians to 
SEMT guidelines for the management of type 2 diabetes in Turkey: ADMIRE study. 
Turk J Endocrin Metab (Turk JEM) 2010; 14: 66-72. 
Adherence to Guidelines and Its Effect on  
Glycemic Control During the Management of Type 2 Diabetes in Turkey: The ADMIRE Study 
 
169 
Presentations: 
2. Satman I, Imamoglu S, Yilmaz C, Ozkaya RD, Ozdemir O. Adherence of internists and 
family physicians to SEMT guidelines for type 2 diabetes mellitus in Turkey. 11th ECE 
2009, 25-29 April 2009, Istanbul, Turkey, Poster No. 295. 
3. Satman I, Yilmaz C, Imamoglu S. Interrelationship among chronic complications, 
adherence of guidelines and degree of metabolic control in type 2 DM patients in Turkey. 
91th Annual Meeting ENDO 09, 10-13 June 2009, Washington DC, USA, Poster No. 515. 
4. Satman I, Imamoglu S, Yilmaz C. Relationship between adherence of physicians and the 
degree of glycaemic control in type 2 DNM patients in Turkey. 69th Scientific Session of 
ADA, 5-9 June 2009, New Orleans, USA, Poster No. 900. 
5. Satman I, Imamoglu S, Yilmaz C and ADMIRE Study Group. Factors related with the 
adherence of physicians to diabetes guidelines in type 2 DM patients in Turkey. ECE 
2011, 30 April-04 May 2011, Rotterdam, The Netherlands, Poster No. 672. 
6. Satman I, Imamoglu S, Yilmaz C. Impact of adherence to guidelines on glycemic control 
and chronic complications in Turkey. 71st Scientific Session of ADA, 24-28 June 2011, 
New Orleans, USA, Poster No. 1189-P. 
7. Satman I, Imamoglu S, Yilmaz C. Relationship between adherence of physicians to 
SEMT diabetes guidelines and degree of glycemic control in type 2 DM patients in 
Turkey. 93rd Annual Meeting ENDO 09, 4-7 June 2011, Boston, USA, Poster No. P2-
758. 
8. Satman I, Imamoglu S, Yilmaz C and ADMIRE Study Group. Türkiye’de Hekimlerin 
Tip 2 Diyabette TEMD Kılavuzuna Uyum Derecesi ile Glisemik Kontrol Arasındaki 
İlişkinin Değerlendirilmesi: ADMIRE Çalışması Birinci Aşama Sonuçları. 32nd 
Congress of Endocrinology and Metabolism Diseases of Turkey (TEMD) 2010, 13-17 
October 2010, Antalya, Turkey. 
9. Satman I, Imamoglu S, Yilmaz C and ADMIRE Study Group. Comparison of the 
Methods for Evaluation of Adherence to Type 2 DM Guidelines: Retrospective Chart 
Review vs. Prospective Patient Follow-up. World Diabetes Congress (WDC), IDF 2011, 
4-8 December 2011, Dubai. 
ADMIRE Study was performed by Diabetes Study Group of The Society of Endocrinology 
and Metabolism of Turkey (SEMT), with an unrestricted educational grant from sanofi. 
5. References 
[1] Satman I, Yilmaz T, Şengul A, Salman S, Salman F, Uygur S, Baştar I, Tutuncu Y, Sargin 
M, Dinccag N, Karsidag K, Kalaca S, Ozcan C, King H, and the TURDEP Group (2002) 
Population-Based Study of Diabetes and Risk Characteristics in Turkey: Results of the 
Turkish Diabetes Epidemiology Study (TURDEP). Diabetes care. 25: 1551-1556. 
[2] Satman I, Tutuncu Y, Gedik S, Dinccag N, Karsidag K, Yilmaz T, Omer B, Kalaca S, 
Telci A, Cakir B, Tuomilehto J (2011) Diabetes Epidemic in Turkey: Results of The 
 
State of the Art of Therapeutic Endocrinology 
 
170 
Second Population-Based Survey of Diabetes and Risk Characteristics in Turkey 
(TURDEP-II). 47th EASD Annual Meeting, 12-16 Sept. 2011, Lisbon. Diabetologia 54 
(Suppl. 1): 324, PS 007. 
[3] The Diabetes Control and Complications Trial Research Group (1993) The Effect of 
Intensive Treatment of Diabetes on the Development and Progression of Long-Term 
Complications in Insulin-Dependent Diabetes Mellitus. N. engl. j. med. 329: 977-986. 
[4] UK Prospective Diabetes Study Group (1998) Tight Blood Pressure Control and Risk of 
Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38. BMJ. 
317: 703-713. 
[5] Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a Multifactorial 
Intervention on Mortality in Type 2 Diabetes. N. engl. j. med. 358: 580-591. 
[6] Dailey G (2011) Overall Mortality in Diabetes Mellitus: Where Do We Stand Today? 
Diabetes technol. ther. 13 (Suppl. 1): S65-74. 
[7] Dailey G (2011) Early and Intensive Therapy for Management of Hyperglycemia 
and Cardiovascular Risk Factors in Patients with Type 2 Diabetes. Clin. ther. 33: 
665-678. 
[8] O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Blitz G (2007) Clinical Inertia and 
Outpatient Medical Errors. Advances in patient safety. 2: 293-308. 
[9] Grol R, Buchan H (2006) Clinical Guidelines: What Can We Do to Increase their Use? 
Med. j. aust. 185: 301-302. 
[10] Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA (1999) Why Don't 
Physicians Follow Clinical Practice Guidelines? A Framework for Improvement. JAMA. 
282: 1458-1465. 
[11] Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M (2002) The 
Role of Patient, Physician and Systemic Factors in the Management of Type 2 Diabetes 
Mellitus. Fam.  pract. 19: 344-349. 
[12] Satman I, Imamoglu S, Yilmaz C, ve TEMD Diyabet Calisma Grubu (Editorler) (2008) 
Diabetes Mellitus ve Komplikasyonlarinin Tani, Tedavi ve Izlem Kilavuzu. 3. Baski, 
Muka Matbaasi, Istanbul. 
[13] Satman I, Imamoglu S, Yilmaz C, and Diabetes Study Group of SEMT (2010) Clinical 
Practice Guidelines for Diagnosis, Treatment, and Follow-up of Diabetes Mellitus and 
its Complications. Updated 4th Edition. Turkish j. endocrinology and metabolism. 
(Turk Jem) 14 (Suppl. 1). 
[14] Satman I, Imamoglu S, Yilmaz C, Akalin S ve TEMD Diabetes Mellitus Egitim ve 
Calisma Grubu (Editorler) (2011) Diabetes Mellitus ve Komplikasyonlarinin Tani, 
Tedavi ve Izlem Kilavuzu. 5. Baski, Bayt Matbaası, Ankara. 
[15] ADA Clinical Practice Recommendations (2009). Diabetes Care 2009;32(Suppl.1):S13-
61. 
[16] Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in 
type 2 diabetes -a consensus algorithm for the initiation and adjustment of therapy: a 
Adherence to Guidelines and Its Effect on  
Glycemic Control During the Management of Type 2 Diabetes in Turkey: The ADMIRE Study 
 
171 
consensus statement of the American Diabetes Association and the European 
Association for the Study of Diabetes. Diabetes Care 2009;32:1-11. 
[17] Ratsep A, Oja I, Kalda R, Lember M (2007) Family Doctors' Assessment of Patient- and 
Health Care System-Related Factors Contributing to Non-Adherence to Diabetes 
Mellitus Guidelines. Prim. care. diabetes. 1: 93-97.  
[18] Hetlevik I, Holmen J, Midthjell K (1997) Treatment of Diabetes Mellitus--Physicians' 
Adherence to Clinical Guidelines in Norway. Scand. j. prim. health care. 15: 193- 
197. 
[19] Chan GC, Ghazali O, Khoo EM (2005) Management of Type 2 Diabetes Mellitus: Is It in 
Accordance with The Guidelines? Med. j. Malaysia. 60: 578-584. 
[20] James PA, Cowan TM, Graham RP, Majeroni BA (1997) Family Physicians' Attitudes 
About and Use of Clinical Practice Guidelines. J. fam. pract. 45: 341-347. 
[21] Larme AC, Pugh JA (1998) Attitudes of Primary Care Providers Toward Diabetes: 
Barriers to Guideline Implementation. Diabetes care. 21: 1391-1396. 
[22] Zafar A, Davies M, Azhar A, Khunti K (2010) Clinical Inertia in Management of T2DM. 
Prim. care diabetes. 4: 203-207.  
[23] Philips JC, Scheen AJ (2010) Clinical Inertia in the Management of Patients with Type 2 
Diabetes: How to Solve it?. Rev. med. liege. 65: 318-325. 
[24] Albisser AM, Inhaber F (2010) Automation of the Consensus Guidelines in Diabetes 
Care: Potential Impact on Clinical Inertia. Endocr. pract. 16: 992-1002.  
[25] Borgermans L, Goderis G, Van Den Broeke C, Mathieu C, Aertgeerts B, Verbeke G, 
Carbonez A, Ivanova A, Grol R, Heyrman J (2008) A Cluster Randomized Trial to 
Improve Adherence to Evidence-based Guidelines on Diabetes and Reduce Clinical 
Inertia in Primary Care Physicians in Belgium: Study Protocol [NTR 1369]. Implement 
sci. 3: 42.  
[26] Reach G (2008) Patient Non-adherence and Healthcare-provider Inertia are Clinical 
Myopia. Diabetes metab. 34(4 Pt 1): 382-385.  
[27] Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, Argueta R, 
Hull BP, Zimmerman RS (2007) Diabetes Care in Hospitalized Noncritically Ill Patients: 
More Evidence for Clinical Inertia and Negative Therapeutic Momentum. J. hosp. med. 
2: 203-211.  
[28] Ziemer DC, Doyle JP, Barnes CS, Branch WT Jr, Cook CB, El-Kebbi IM, Gallina DL, 
Kolm P, Rhee MK, Phillips LS (2006) An Intervention to Overcome Clinical Inertia 
and Improve Diabetes Mellitus Control in a Primary Care Setting: Improving Primary 
Care of African Americans with Diabetes (IPCAAD) 8. Arch. intern. med. 166: 507-
513. 
[29] Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer 
DC, Barnes CS (2001) Clinical Inertia. Ann. intern. med. 135: 825-834. 
[30] McKinlay JB, Link CL, Freund KM, Marceau LD, O'Donnell AB, Lutfey KL (2007) 
Sources of Variation in Physician Adherence with Clinical Guidelines: Results From a 
Factorial Experiment. J. gen. intern. med. 22: 289-296. 
 
State of the Art of Therapeutic Endocrinology 
 
172 
[31] Gerstein HC, Reddy SS, Dawson KG, Yale JF, Shannon S, Norman G (1999) A 
Controlled Evaluation of a National Continuing Medical Education Programme 
Designed to Improve Family Physicians' Implementation of Diabetes-Specific Clinical 
Practice Guidelines. Diabet med. 16: 964-969. 
